Chief Scientist, Center for Bioethics and Humanities, University of Colorado Anschutz Medical Campus

Professor Lisa Bero provides international leadership for multidisciplinary teams that specialize in studying the integrity, use and implementation of research for health and health policy. She is Professor of Medicine and Public Health and Chief Scientist at the Center for Bioethics and Humanities, University of Colorado Anschutz Medical Campus. She is Senior Editor, Research Integrity and Public Health and Health Systems Network, Cochrane. She has contributed to Cochrane as an author, editor, Centre Director, and member and Co-Chair of Cochrane’s Governing Board. She is also a longtime contributor to the work of the World Health Organization, including serving as a member of the Guideline Review Committee, and as Chair of the Essential Medicines Committee.

Senior Editor, The BMJ

Peter Doshi, PhD, is an associate professor of pharmaceutical health services research at the University of Maryland School of Pharmacy and an editor at The BMJ. His research focuses on the drug approval process, how the risks and benefits of medical products are assessed and communicated, and improving the credibility and accuracy of evidence synthesis and biomedical publications. Doshi campaigns for greater transparency of clinical trial data and has been advocating for full transparency of the data on Covid-19 drugs and vaccines. Doshi leads the Restoring Invisible and Abandoned Trials (RIAT) initiative, which aims to ensure clinical trial publications are accurate, complete, and data are publicly available. He completed a post-doctoral fellowship in comparative effectiveness research at Johns Hopkins University and received his Ph.D. in history, anthropology, and science, technology and society from the Massachusetts Institute of Technology.

Director, Program on Regulation, Therapeutics, and Law (PORTAL)

Aaron S. Kesselheim, MD, JD, MPH is a Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. Within the Division, Aaron created and leads the Program On Regulation, Therapeutics, And Law (PORTAL, www.PORTALresearch.org), an interdisciplinary research core focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law. PORTAL is now among the largest, independent (non-industry-funded) academic centers focusing on these issues in the country (Twitter: @PORTAL_research, @akesselheim). Author of over 450 publications in the peer-reviewed medical and health policy literatures, Aaron has testified before Congress on pharmaceutical policy, medical device regulation, generic drugs, and modernizing clinical trials and is a member of the FDA Peripheral and Central Nervous System Advisory Committee. Aaron is a core faculty member at the HMS Center for Bioethics, where he co-teaches a course on health policy, law, and bioethics and organizes a monthly policy and ethics seminar series. Aaron also serves as the Sidley Austin-Robert D. McLean Visiting Professor of Law at Yale Law School, where he teaches a yearly course on Food and Drug Administration Law and Policy (and at the Yale School of Public Health). He recently developed a massive open online course called Prescription Drug Regulation, Cost, and Access: Current Controversies in Context disseminated via the HarvardX platform to over 80,000 participants world-wide (and still available for viewing here: https://www.edx.org/course/the-fda-and-prescription-drugs-current-controversies-in-context). He is the editor-in-chief of the Journal of Law, Medicine, and Ethics and is a member of the Perspectives advisory board for the New England Journal of Medicine. In 2020, he was elected to the National Academy of Medicine.

Assistant Professor, Bond University

Dr Ray Moynihan is an Assistant Professor at the Institute for Evidence-Based Healthcare at Bond University in Australia and has a global reputation for tackling the problems of too much medicine, and commercial distortion of science. A former award-winning journalist, Ray has produced 4 books on the business of medicine, including Selling Sickness, which was written during his time in Washington D.C., and has been translated into 12 languages. A one-time Harkness fellow at Harvard University, Ray’s published in the NEJM, PLOS Medicine, Lancet and BMJ. He recently presented The Recommended Dose podcast series, produced by Cochrane Australia and co-promoted by BMJ. Ray is a long-term survivor of Motivational Deficiency Disorder and currently an Australian NHMRC Early Career Fellow. In 2019 he co-led a BMJ initiative calling for a global move towards more independence from industry in medical research, education and practice.

Editor-in-Chief, JAMA Internal Medicine; Professor, University of California, San Francisco

Rita F. Redberg, MD, MSc, is a cardiologist and Professor of Medicine at the University of California, San Francisco since 1990 and Core Faculty, Philip R Lee Institute for Health Policy Studies. Dr. Redberg is the Chief Editor of JAMA Internal Medicine (formerly Archives of ) since 2009 and has spearheaded the journal’s new focus on health care reform and “less is more”, which highlights areas of health care with no known benefit and definite risks. Her research interests are in the area of health policy and technology assessment, and how to promote high value care, focusing on high risk medical devices as well as the need for inclusion of women in clinical trials of such devices.

She has had a long standing commitment to women and heart disease and cofounded the UCSF Center of Excellence in Women’s Health in 1997. She was honored to receive the Women’s Day Red Dress Award in 2011 for her leadership in the area of heart disease in women and the Bay Area American Heart Association Red Dress Award in 2010. She is a proud member of the Women’s Heart Alliance.

Dr. Redberg recently completed a 6 year term on the Medicare Payment Advisory Commission, which advises Congress on Medicare payment issues. She also served on the Medicare Evidence, Development and Coverage Advisory Committee from 2003-2006 and was reappointed as Chairwoman of MEDCAC from 2012 - 2016. Dr Redberg is a member of the California Technology Assessment Forum, the Medical Policy Technology and Advisory Committee, Blue Cross Blue Shield Medical Advisory Panel and served on the Food and Drug Administration Cardiovascular Devices Expert Panel. She was a member of the American College of Cardiology’s (ACC) Clinical Quality Committee and served on the Quality in Technology Work Group. She chaired the AHA/ACC Writing Group on Primary Prevention Performance Measures.

She has given Congressional testimony multiple times in hearings related to the issue of balancing safety and innovation in medical device approvals. Dr. Redberg worked in the office of Senator Hatch and with the Senate Judiciary Committee on FDA-related matters during her tenure as a Robert Wood Johnson Health Policy Fellow, 2003-2006.

Dr. Redberg was elected to the National Academy of Medicine (formerly Institute of Medicine, IOM). She was a member of the IOM’s Learning Health Care Committee,which produced the report Best Care at Lower Cost in September 2012 and of the National Academy of Medicine writing group on A Learning System for Military Trauma Care.

Dr. Redberg has authored several books, including You Can Be a Woman Cardiologist, Heart Healthy: The Step-by-Step Guide to Preventing and Healing Heart Disease, and Betty Crocker Cookbook for Women: the Complete Guide to Women’s Health and Wellness at Every Stage of Life. She has done hundreds of radio, television and newspaper interviews on health related topics including being featured in The New York Times, Wall Street Journal, USA Today, National Public Radio and the Today Show. Dr. Redberg graduated from Cornell University and the University of Pennsylvania Medical School and has a Master of Science in Health Policy and Administration from the London School of Economics.

Associate Director, Center for Patient Safety Research and Practice, Brigham and Women's Center

Dr. Gordon (Gordy) Schiff is a practicing general internist and Associate Director of Brigham and Women’s Center for Patient Safety Research, and Practice, Quality and Safety Director for the Harvard Medical School (HMS) Center for Primary Care and Associate Professor of Medicine at HMS.

Before coming to Boston in 2007, he worked for more than three decades at Cook County Hospital, Chicago’s large public hospital serving the city’s underserved and uninsured population and was Professor of Medicine at Rush Medical College. At Cook County he directed the General Medicine Clinic, led the Department of Medicine Quality program, and Chaired the institution’s P&T (Formulary) Committee.

He has published widely in the areas of medication and diagnosis safety and was a reviewer and contributor to the 2015 National Academy of Medicine (IOM) Report Improving Diagnosis in Health Care. He is PI of multiple AHRQ, CRICO, NSPF, and Moore Foundation-funded projects related to improving medication safety and application of health IT to safer medication use, including the Massachusetts based PRIDE (Primary-care Research in Diagnosis Errors) Learning Network which is a coalition of groups sharing and learning from cases of diagnostic error. He has authored more than 200 papers and chapters including several recent papers detailing conservative prescribing and diagnosis practices as ways to transform current unsafe and costly use of drugs and diagnostic testing.

He is recipient of an award from the Arnold P. Gold Foundation for Medical Humanism to study professional-patient boundaries and relationships, the 2019 Mark Graber Diagnosis Safety Award by the Society for Improving Diagnosis in Medicine, and in 2020 was awarded the John Eisenberg Award by the National Quality Forum (NQF) and the Joint Commission. He is the author/editor of the Joint Commission Resources book Getting Results: Reliably Communicating and Acting on Critical Test Results. He chairs the editorial board of Medical Care as well as is on editorial boards of the Journal Public Health Policy and BMJ Quality and Safety in Healthcare.